Lyell Immunopharma Inc (LYEL): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 37,875 US Dollar | 5 | 2 | 0 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 24.505.141 | 6,66 | 7,91 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Lyell Immunopharma Inc
Mitarbeiter 161
Handelsplatz NASDAQ
Ticker Symbol LYEL
IPO Datum 2021-06-17
Adresse 201 Haskins Way, South San Francisco, CA, United States, 94080
Webseite https://www.lyell.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Richard D. Klausner M.D. | Founder & Executive Chairman |
| 2 | Dr. Lynn Seely M.D., Ph.D. | Principal Executive Officer, President, CEO & Director |
| 3 | Mr. Stephen J. Hill M.B.A. | Chief Operating Officer |
| 4 | Dr. Gary K. Lee Ph.D. | Chief Scientific Officer |
| 5 | Prof. Stanley R. Riddell M.D. | Founder & Scientific Advisor |
| 6 | Dr. Crystal L. Mackall M.D. | Founder & Scientific Advisor |
| 7 | Ms. Smital Shah M.B.A. | Principal Financial Officer, CFO & Chief Business Officer |
| 8 | Nellie Dillery | Director of Accounting |
| 9 | Mr. Mark A. Meltz J.D. | General Counsel & Corporate Secretary |
| 10 | Ms. Ann Tomlin | Chief Human Resources Officer |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | ARCH VENTURE CORP | 13,25% | 35,49 Mio. USD |
| 2 | GSK PLC | 6,17% | 16,53 Mio. USD |
| 3 | Vanguard Capital Management, LLC | 3,21% | 8,60 Mio. USD |
| 4 | Orland Properties Ltd | 3,08% | 8,25 Mio. USD |
| 5 | BlackRock Inc | 2,96% | 7,92 Mio. USD |
| 6 | Almitas Capital LLC | 2,37% | 6,36 Mio. USD |
| 7 | Foresite Capital Management V, LLC | 1,94% | 5,21 Mio. USD |
| 8 | Millennium Management LLC | 1,50% | 4,02 Mio. USD |
| 9 | Opaleye Management Inc | 1,40% | 3,76 Mio. USD |
| 10 | venBio Partners LLC | 1,38% | 3,69 Mio. USD |
| 11 | Geode Capital Management, LLC | 1,27% | 3,40 Mio. USD |
| 12 | Alphabet Inc | 1,20% | 3,21 Mio. USD |
| 13 | State Street Corp | 0,76% | 2,03 Mio. USD |
| 14 | HSG Holding Ltd | 0,62% | 1,67 Mio. USD |
| 15 | Renaissance Technologies Corp | 0,53% | 1,42 Mio. USD |
| 16 | Northern Trust Corp | 0,48% | 1,30 Mio. USD |
| 17 | Qube Research & Technologies | 0,45% | 1,21 Mio. USD |
| 18 | Charles Schwab Investment Management Inc | 0,44% | 1,18 Mio. USD |
| 19 | Marshall Wace Asset Management Ltd | 0,43% | 1,16 Mio. USD |
| 20 | Velan Capital Investment Management LP | 0,43% | 1,15 Mio. USD |